These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38975247)

  • 1. Recurrent
    Mehta N; Goodenough D; Gupta NK; Thomas S; Mehta C; Prakash R; Woodworth MH; Kraft CS; Fridkin SK
    Open Forum Infect Dis; 2024 Jul; 11(7):ofae309. PubMed ID: 38975247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fecal microbiota transplantation for the treatment of recurrent Clostridioides difficile (Clostridium difficile).
    Minkoff NZ; Aslam S; Medina M; Tanner-Smith EE; Zackular JP; Acra S; Nicholson MR; Imdad A
    Cochrane Database Syst Rev; 2023 Apr; 4(4):CD013871. PubMed ID: 37096495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fecal microbiota transplantation for recurrent Clostridioides difficile infection in patients with concurrent ulcerative colitis.
    Porcari S; Severino A; Rondinella D; Bibbò S; Quaranta G; Masucci L; Maida M; Scaldaferri F; Sanguinetti M; Gasbarrini A; Cammarota G; Ianiro G
    J Autoimmun; 2023 Dec; 141():103033. PubMed ID: 37085337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness and Safety of Colonic and Capsule Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection.
    Vaughn BP; Fischer M; Kelly CR; Allegretti JR; Graiziger C; Thomas J; McClure E; Kabage AJ; Khoruts A
    Clin Gastroenterol Hepatol; 2023 May; 21(5):1330-1337.e2. PubMed ID: 36126907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of fecal microbiota transplantation to treat and prevent recurrent
    Ali H; Khurana S; Ma W; Peng Y; Jiang ZD; DuPont H; Zhang HC; Thomas AS; Okhuysen P; Wang Y
    J Cancer; 2021; 12(21):6498-6506. PubMed ID: 34659541
    [No Abstract]   [Full Text] [Related]  

  • 6. Gram-Negative Taxa and Antimicrobial Susceptibility after Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection.
    Steed DB; Wang T; Raheja D; Waldman AD; Babiker A; Dhere T; Kraft CS; Woodworth MH
    mSphere; 2020 Oct; 5(5):. PubMed ID: 33055258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short- and long-term follow-up after fecal microbiota transplantation as treatment for recurrent
    van Lingen EE; Baunwall SSMD; Lieberknecht SSC; Benech NN; Ianiro GG; Sokol HH; Gasbarrini AA; Cammarota GG; Eriksen MMK; van der Meulen-de Jong AAE; Terveer EEM; Verspaget HHW; Vehreschild MM; Hvas CCL; Keller JJJ
    Therap Adv Gastroenterol; 2023; 16():17562848231156285. PubMed ID: 36910163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbiota restoration therapies for recurrent
    DuPont HL; DuPont AW; Tillotson GS
    Therap Adv Gastroenterol; 2024; 17():17562848241253089. PubMed ID: 38800353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-world Use of Bezlotoxumab and Fecal Microbiota Transplantation for the Treatment of
    de la Villa S; Herrero S; Muñoz P; Rodríguez C; Valerio M; Reigadas E; Álvarez-Uría A; Alcalá L; Marín M; Olmedo M; Kestler M; Chamorro E; Bouza E
    Open Forum Infect Dis; 2023 Feb; 10(2):ofad028. PubMed ID: 36776780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of recurrent Clostridioides difficile infection: A systematic review of randomized controlled trials.
    Madoff SE; Urquiaga M; Alonso CD; Kelly CP
    Anaerobe; 2020 Feb; 61():102098. PubMed ID: 31493500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fecal microbiota transplantation for recurrent Clostridioides difficile infection in frail and very old patients.
    Montalto M; Gallo A; Agnitelli MC; Pellegrino S; Lipari A; Pero E; Covino M; Landi F; Gasbarrini A; Cammarota G; Ianiro G
    J Am Geriatr Soc; 2023 Nov; 71(11):3530-3537. PubMed ID: 37458581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Recurrent
    Azimirad M; Yadegar A; Gholami F; Shahrokh S; Asadzadeh Aghdaei H; Ianiro G; Suzuki H; Cammarota G; Zali MR
    J Inflamm Res; 2020; 13():563-570. PubMed ID: 32982371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of a Multidisciplinary Clinic in Evaluating Recurrent
    Shin JH; Chaplin AS; Hays RA; Kolling GL; Vance S; Guerrant RL; Archbald-Pannone L; Warren CA
    J Clin Med; 2019 Jul; 8(7):. PubMed ID: 31315214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor, patient age and exposure to antibiotics are associated with the outcome of faecal microbiota transplantation for recurrent Clostridioides difficile infection: A prospective cohort study.
    Baunwall SMD; Hansen MM; Andreasen SE; Eriksen MK; Rågård N; Kelsen J; Grosen AK; Mikkelsen S; Erikstrup C; Dahlerup JF; Hvas CL
    Aliment Pharmacol Ther; 2023 Sep; 58(5):503-515. PubMed ID: 37482926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term durability and safety of fecal microbiota transplantation for recurrent or refractory Clostridioides difficile infection with or without antibiotic exposure.
    Lee CH; Chai J; Hammond K; Jeon SR; Patel Y; Goldeh C; Kim P
    Eur J Clin Microbiol Infect Dis; 2019 Sep; 38(9):1731-1735. PubMed ID: 31165961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations and Prediction of Functional Profiles of Gut Microbiota After Fecal Microbiota Transplantation for Iranian Recurrent
    Azimirad M; Jo Y; Kim MS; Jeong M; Shahrokh S; Asadzadeh Aghdaei H; Zali MR; Lee S; Yadegar A; Shin JH
    J Inflamm Res; 2022; 15():105-116. PubMed ID: 35023946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Efficacy and Safety of Fecal Microbiota Transplantation for Treatment of Recurrent Clostridioides difficile Infection.
    Perler BK; Chen B; Phelps E; Allegretti JR; Fischer M; Ganapini V; Krajiceck E; Kumar V; Marcus J; Nativ L; Kelly CR
    J Clin Gastroenterol; 2020 Sep; 54(8):701-706. PubMed ID: 32011405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Faecal microbiota transplantation in the treatment of recurrent intestinal Clostridioides difficile infection - a ten-year single-center experience.
    Pipek B; Valentová H; Fojtík P; Urban O
    Cas Lek Cesk; 2022; 161(3-4):126-130. PubMed ID: 36100450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal microbiota transplantation as therapy for recurrent Clostridioides difficile infection is associated with amelioration of delirium and accompanied by changes in fecal microbiota and the metabolome.
    Gotoh K; Sakaguchi Y; Kato H; Osaki H; Jodai Y; Wakuda M; Také A; Hayashi S; Morita E; Sugie T; Ito Y; Ohmiya N
    Anaerobe; 2022 Feb; 73():102502. PubMed ID: 34896553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alteration of gut microbial composition associated with the therapeutic efficacy of fecal microbiota transplantation in Clostridium difficile infection.
    Lee PC; Chang TE; Wang YP; Lee KC; Lin YT; Chiou JJ; Huang CW; Yang UC; Li FY; Huang HC; Wu CY; Huang YH; Hou MC
    J Formos Med Assoc; 2022 Sep; 121(9):1636-1646. PubMed ID: 34836663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.